A phase IIb study of selinexor in combination with daratumumab in patients with daratumumab-refractory multiple myeloma
Susan Kumka, David H. Vesole, Eli Zolotov, David S. Siegel et al.
Journal
Haematologica
Topics
Multiple Myeloma Research and Treatments
article
A phase IIb study of selinexor in combination with daratumumab in patients with daratumumab-refractory multiple myeloma
Susan Kumka, David H. Vesole, Eli Zolotov, David S. Siegel, Kimberley Doucette, Harsh Parmar, Palka Anand, Aimee Chappell, Alexandra Della Pia, Noa Biran, Patrick Roney, Joshua Zenreich, Adolfo Aleman, Rena Feinman, Pooja Phull, Jaeil Ahn, Bianca DeAgresta, Monique Pace, E.‐M. Rutanen, Lisa Biamonte
article en
Abstract
No abstract available for this paper.
Publication Tag
HaematologicaVol. 110(10)
Institutions
Hackensack University Medical Center (US), Georgetown University (US), Georgetown University Medical Center (US), Applied Biomathematics (United States) (US), Hackensack Meridian Health (US), Center for Discovery (US)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
A phase IIb study of selinexor in combination with daratumumab in patients with daratumumab-refractory multiple myeloma — Susan Kumka, David H. Vesole, et al. · Haematologica (2025) | TGRS Research Map | TGRS